Group items tagged

Novo Nordisk became the world's first pharmaceutical company to publish an environmental profit and loss account, which places a financial value on the company's environmental impacts. The analysis revealed that Novo Nordisk caused over $305 million in environmental damage during 2011, with the company's supply chain accounting for 75% its impact.

Novo Nordisk, a global healthcare company specialising in diabetes, obesity and other serious chronic diseases, published its Annual Report 2017 online today at novonordisk.com/annualreport. It is the company's fourteenth integrated annual report accounting for the company's financial, social and environmental performance.